Apyx Medical Corp - Common Stock (APYX)

Historical Holders from Q4 2018 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
APYX on Nasdaq
Shares outstanding
34,967,317
Price per share
$2.14
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
15,737,051
Holdings value
$33,674,427
% of all portfolios
0%
Share change
-94,064
Value change
-$213,866
Average buys %
+0%
Average sells %
-0%
Number of holders
47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apyx Medical Corp - Common Stock (APYX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% $4,296,679 3,493,235 Nantahala Capital Management, LLC 31 Dec 2024
As of 30 Sep 2025 Apyx Medical Corp - Common Stock (APYX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15,737,051 shares of 34,967,317 outstanding shares and own 45% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Apyx Medical Corp - Common Stock (APYX) own 44% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 9.5% 3,338,048 0% 0.44% $7,143,423
Archon Capital Management LLC 9.4% 3,281,486 0% 4.2% $7,022,380
ROYCE & ASSOCIATES LP 7.1% 2,474,399 +1.4% 0.05% $5,295,214
VANGUARD GROUP INC 4.4% 1,528,947 +3.6% 0% $3,271,947
Silverberg Bernstein Capital Management LLC 2.8% 986,503 +10% 1.3% $2,111,204
COMMONWEALTH EQUITY SERVICES, LLC 1.9% 663,541 0% 0% $1,420,000
HORIZON KINETICS ASSET MANAGEMENT LLC 1.8% 615,000 0% 0.02% $1,316,100
BlackRock, Inc. 1.5% 509,763 +1.3% 0% $1,090,893
Taylor Frigon Capital Management LLC 1.3% 470,652 -1.7% 0.5% $1,007,195
GEODE CAPITAL MANAGEMENT, LLC 1% 351,278 +0.47% 0% $751,918
RENAISSANCE TECHNOLOGIES LLC 0.63% 221,697 +22% 0% $474,432
Kingsview Wealth Management, LLC 0.55% 193,043 +0.75% 0.01% $413,112
PERCEPTIVE ADVISORS LLC 0.43% 150,000 0% 0.01% $321,000
Caption Management, LLC 0.35% 123,932 +15% 0.02% $265,214
STATE STREET CORP 0.31% 109,306 0% 0% $233,915
NORTHERN TRUST CORP 0.31% 106,806 -10% 0% $228,565
PERKINS CAPITAL MANAGEMENT INC 0.23% 81,000 -64% 0.15% $173,340
RPg Family Wealth Advisory, LLC 0.22% 76,250 0.04% $163,175
Private Advisor Group, LLC 0.19% 66,720 -77% 0% $142,781
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.18% 61,601 0% 0% $131,826
SALEM INVESTMENT COUNSELORS INC 0.13% 45,500 0% $97,370
FRANKLIN RESOURCES INC 0.08% 27,489 0% $58,826
DIMENSIONAL FUND ADVISORS LP 0.07% 24,664 -67% 0% $52,781
GREENWOOD CAPITAL ASSOCIATES LLC 0.07% 22,789 0% 0.01% $48,768
XTX Topco Ltd 0.06% 21,545 0% $46,106

Institutional Holders of Apyx Medical Corp - Common Stock (APYX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 15,737,051 $33,674,427 -$213,866 $2.14 47
2025 Q2 15,811,115 $35,574,319 +$288,222 $2.25 39
2025 Q1 15,792,917 $21,635,134 -$202,683 $1.37 43
2024 Q4 15,925,107 $25,160,336 +$4,988,210 $1.58 45
2024 Q3 12,768,538 $15,832,453 -$148,543 $1.24 45
2024 Q2 12,878,182 $17,255,824 -$231,261 $1.34 48
2024 Q1 13,062,182 $17,763,898 -$10,492,849 $1.36 51
2023 Q4 328,380 $860,356 -$48,000 $2.62 1
2023 Q3 18,315,518 $58,610,955 -$232,431 $3.20 60
2023 Q2 18,409,455 $92,597,902 -$2,494,060 $5.03 54
2023 Q1 20,085,109 $58,156,535 +$5,925,052 $2.88 54
2022 Q4 18,189,785 $42,561,844 -$5,347,763 $2.34 47
2022 Q3 20,880,925 $93,755,141 -$1,169,490 $4.49 51
2022 Q2 21,031,854 $123,244,150 +$6,931,890 $5.86 61
2022 Q1 19,564,733 $127,814,812 -$1,435,660 $6.53 69
2021 Q4 19,106,864 $244,910,256 -$2,634,740 $12.82 74
2021 Q3 18,881,955 $261,279,213 -$2,533,804 $13.85 74
2021 Q2 19,009,441 $195,898,403 -$11,509,411 $10.31 72
2021 Q1 18,953,711 $183,087,913 +$4,255,099 $9.66 66
2020 Q4 18,539,563 $133,544,214 +$4,872,105 $7.20 62
2020 Q3 16,405,211 $77,257,627 -$782,806 $4.71 57
2020 Q2 17,985,869 $99,885,990 +$1,827,162 $5.55 58
2020 Q1 16,123,706 $57,886,783 -$4,211,242 $3.59 63
2019 Q4 18,241,899 $154,335,344 +$825,713 $8.46 67
2019 Q3 17,760,180 $120,211,837 +$8,194,201 $6.77 65
2019 Q2 17,318,462 $116,360,053 +$14,336,995 $6.72 66
2019 Q1 15,330,673 $96,737,645 +$87,020,010 $6.31 77
2018 Q4 924,973 $5,994,000 +$5,993,980 $6.48 2